Genmab A/s

(NASDAQ) GMAB

Current Price$26.85

Market Cap$15.80B

Since IPO (2013)+638%

5 Year-28%

1 Year+26%

1 Month-3%

Genmab A/s Financials at a Glance

Market Cap

$15.80B

Revenue (TTM)

$8.65B

Net Income (TTM)

$2.76B

EPS (TTM)

$1.55

P/E Ratio

16.96

Dividend

$0.00

Beta (Volatility)

0.72 (Low)

Dividend

$0.00

Beta (Volatility)

0.72 (Low)

Price

$26.85

Volume

27,988

Open

$26.26

Price

$26.85

Volume

27,988

Open

$26.26

Previous Close

$26.45

Daily Range

$26.24 - $26.91

52-Week Range

$18.89 - $35.43

Dividend

$0.00

Beta (Volatility)

0.72 (Low)

Price

$26.85

Volume

27,988

Open

$26.26

Previous Close

$26.45

Daily Range

$26.24 - $26.91

52-Week Range

$18.89 - $35.43

GMAB News

Person checking medicine on a shelf in a pharmacy

Are There Good Investments Among 2019's Biotech IPOs?

David HaenOct 2, 2019

GMAB: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genmab A/s

Industry

Biotechnology

Sector

Health Care

Employees

3,029

CEO

Jan G. J. van de Winkel, PhD

Website

www.genmab.com

Headquarters

Copenhagen, 1560, DK

GMAB Financials

Key Financial Metrics (TTM)

Gross Margin

94%

Operating Margin

37%

Net Income Margin

21%

Return on Equity

18%

Return on Capital

59%

Return on Assets

30%

Earnings Yield

5.90%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$15.80B

Shares Outstanding

597.31M

Volume

27.99K

Avg. Volume

1.62M

Financials (TTM)

Gross Profit

$3.41B

Operating Income

$1.25B

EBITDA

$1.32B

Operating Cash Flow

$1.19B

Capital Expenditure

$37.03M

Free Cash Flow

$1.15B

Cash & ST Invst.

$1.71B

Total Debt

$5.43B

Genmab A/s Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.05B

-83.6%

Gross Profit

$974.05M

-84.0%

Gross Margin

92.34%

N/A

Market Cap

$15.80B

N/A

Market Cap/Employee

$5.99M

N/A

Employees

2,638

N/A

Net Income

$30.91M

-99.2%

EBITDA

$242.27M

-89.7%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$3.71B

-118.5%

Accounts Receivable

$1.15B

-82.8%

Inventory

$17.96M

-71.0%

Long Term Debt

$5.13B

+448.0%

Short Term Debt

$291.00M

+216.3%

Return on Assets

30.26%

N/A

Return on Invested Capital

59.45%

N/A

Free Cash Flow

$287.35M

-4.0%

Operating Cash Flow

$300.34M

-8.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ZBHZimmer Biomet Holdings, Inc.

ZBHZimmer Biomet Holdings, Inc.$83.44+0.65%

THCTenet Healthcare Corporation

THCTenet Healthcare Corporation$185.19+1.05%

SMMTSummit Therapeutics Inc.

SMMTSummit Therapeutics Inc.$17.05+5.80%

INCYIncyte Corporation

INCYIncyte Corporation$96.89-0.02%

ROIVRoivant Sciences Ltd.

ROIVRoivant Sciences Ltd.$28.12+1.03%

EXELExelixis, Inc.

EXELExelixis, Inc.$44.02+0.78%

ILMNIllumina, Inc.

ILMNIllumina, Inc.$139.44+2.70%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.48+2.67%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.21+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.74+0.01%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$45.65+0.03%

PNSkycorp Solar Group

PNSkycorp Solar Group$5.53+0.93%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.09-0.09%

ADTADT

ADTADT$7.08-0.06%

Questions About GMAB

What is the current price of Genmab A/s?

Genmab A/s is trading at $26.88 per share.

What is the 52-week range for Genmab A/s?

Over the past 52 weeks, Genmab A/s has traded between $18.89 and $35.43.

How much debt does Genmab A/s have?

As of the most recent reporting period, Genmab A/s reported total debt of $5.43B.

How much cash does Genmab A/s have on hand?

Genmab A/s reported $1.71B in cash and cash equivalents in its most recent financial results.

What is Genmab A/s’s dividend yield?

Genmab A/s does not currently have a dividend yield.

Genmab A/s

Genmab A/s Financials at a Glance

GMAB News

Why Genmab Stock Popped on Friday

Why Genmab Stock Was Marching Higher Today

Why Genmab Stock Smashed It on Monday

Genmab Revenue Surges 18% in Q3

AbbVie Signs $3.9 Billion Oncology Deal with Genmab

Are There Good Investments Among 2019's Biotech IPOs?

GMAB: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Genmab A/s

GMAB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Genmab A/s Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GMAB

What is the current price of Genmab A/s?

What is the 52-week range for Genmab A/s?

How much debt does Genmab A/s have?

How much cash does Genmab A/s have on hand?

What is Genmab A/s’s dividend yield?

Premium Investing Services